arrow
Back
C

Carla J. de Boer

Johnson & Johnson

18H-index
55Paper Count
2.9KCitation Count
Published Papers 10
Publication Date
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
err2024-09-17
err0
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
err2024-01-25
err106
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; Nijhof, Inger S.; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Sureda Balari, Anna; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
err2017-09-01
err81
errOAAI
errRathkopf, D. E.; Smith, M. R.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Higano, C. S.; Alumkal, J. J.; Hauke, R.; Tutrone, R. F.; Saleh, M.; Maneval, E. Chow; Thomas, S.; Ricci, D. S.; Yu, M. K.; de Boer, C. J.; Trinh, A.; Kheoh, T.; Bandekar, R.; Scher, H. I.; Antonarakis, E. S.
errShare
errSave
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone
err2017-07-13
err76
errOAAI
errRathkopf, Dana E.; Antonarakis, Emmanuel S.; Shore, Neal D.; Tutrone, Ronald F.; Alumkal, Joshi J.; Ryan, Charles J.; Saleh, Mansoor; Hauke, Ralph J.; Bandekar, Rajesh; Maneval, Edna Chow; de Boer, Carla J.; Yu, Margaret K.; Scher, Howard I.
errShare
errSave
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
err2016-12-01
err114
errOAAI
errSmith, Matthew R.; Antonarakis, Emmanuel S.; Ryan, Charles J.; Berry, William R.; Shore, Neal D.; Liu, Glenn; Alumkal, Joshi J.; Higano, Celestia S.; Maneval, Edna Chow; Bandekar, Rajesh; de Boer, Carla J.; Yu, Margaret K.; Rathkopf, Dana E.
errShare
errSave
Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
err2015-08-01
err1
PREAI
errRathkopf, Dana E.; Smith, Matthew R.; Antonarakis, Emmanuel S.; Ryan, Charles J.; Berry, William R.; Shore, Neal D.; Liu, Glenn; Higano, Celestia; Alumkal, Joshi J.; Hauke, Ralph; Tutrone, Ronald; Saleh, Mansoor; Maneval, Edna Chow; Thomas, Shibu; Ricci, Deborah; Yu, Margaret K.; de Boer, Carla J.; Trinh, Angela; Kheoh, Thian; Bandekar, Rajesh; Scher, Howard I.
errShare
errSave
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma
err2015-04-14
err101
errOAAI
errvon Tresckow, Bastian; Morschhauser, Franck; Ribrag, Vincent; Topp, Max S.; Chien, Caly; Seetharam, Shobha; Aquino, Regina; Kotoulek, Sonja; de Boer, Carla J.; Engert, Andreas
errShare
errSave
NOVEL ANTIANDROGEN ARN-509 IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
err2015-04-01
err0
PREAI
errShore, Neal D.; Antonarakis, Emmanuel S.; Ryan, Charles J.; Berry, William R.; Liu, Glenn; Higano, Celestia; Maneval, Edna Chow; Bandekar, Rajesh; de Boer, Carla J.; Todd, Mary B.; Yu, Margaret K.; Rathkopf, Dana E.; Smith, Matthew R.
errShare
errSave
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
err2014-06-15
err176
PREAI
errBrana, Irene; Calles, Antonio; LoRusso, Patricia M.; Yee, Lorrin K.; Puchalski, Thomas A.; Seetharam, Shobha; Zhong, Bob; de Boer, Carla J.; Tabernero, Josep; Calvo, Emiliano
errShare
errSave